All cases
General·CA-1

Lap Chole & End-Stage Renal Disease (ESRD): Metabolic Logic

General specialty scenario focusing on electrolyte optimization, diabetic autonomic neuropathy, and chronic organ failure.

The stem

A 46 y.o. man is scheduled for a laparoscopic cholecystectomy. PMH: Type I DM, retinopathy, neuropathy, and End-Stage Renal Disease (ESRD) on hemodialysis. Last HD was yesterday. K+ 5.3 mEq/L. Mallampati 3.

Focus

Management of hyperkalemia, diabetic autonomic neuropathy (delayed gastric emptying), and cardiovascular risk in End-Stage Renal Disease (ESRD).

Examination relevance

A 'staple' board scenario that pivots from simple general surgery into multi-system metabolic crises (Advanced Cardiovascular Life Support (ACLS), hyperkalemia, difficult airway).

Want to run this case against a live examiner?

Practice this case

Expert sample response

This End-Stage Renal Disease (ESRD) patient needs careful management of his volume status and electrolytes, especially potassium (K+). With a baseline K+ of 5.3, I will avoid succinylcholine and instead use rocuronium for any required muscle relaxation, which I will reverse with sugammadex to ensure complete recovery without reliance on renal excretion.

I will request the surgeon to use a low-pressure pneumoperitoneum to minimize the impact on venous return and renal blood flow, although his native kidneys are already non-functional. I will avoid any nephrotoxic agents and monitor for ECG changes indicative of hyperkalemia during the procedure. I'll maintain a 'fluid-restrictive' strategy to prevent pulmonary edema, as he cannot excrete excess volume. Post-operatively, I will coordinate with the nephrology team for scheduled dialysis, targeting within 24 hours of the surgery while ensuring adequate pain control without overly relying on renally-cleared opioids.

Full walkthrough

What the Examiner Is Testing

This case tests whether you understand the drug modifications required for ESRD — specifically avoiding succinylcholine, choosing rocuronium with sugammadex reversal, and understanding which opioids are safe. The examiner also wants you to flag the gastroparesis aspiration risk from his diabetic neuropathy.

The Board Trap

The trap is using succinylcholine because "the K is only 5.3 — that's not that high." Succinylcholine causes a predictable rise in serum potassium of 0.5 to 1 mEq/L via receptor upregulation with muscle fasciculations. In a patient with ESRD who cannot excrete potassium, starting at 5.3 and adding 1.0 puts you at 6.3 — in the danger zone for arrhythmia. Succinylcholine is contraindicated.

Walk-Through: How This Case Plays Out

Examiner: His K+ is 5.3. Is it safe to proceed?

Me: I'd say proceed with caution. 5.3 is elevated and his dialysis was yesterday — that's 24 hours ago. I'd check an EKG looking for peaked T-waves or widening QRS. If it's clean, I'm comfortable proceeding but I would not use succinylcholine. I'll use rocuronium 0.6-1.2 mg/kg for intubation — he's a Mallampati 3 with diabetic gastroparesis, so I want rapid conditions without the potassium risk. I'll reverse with sugammadex at the end since he can't rely on neostigmine clearance.

Examiner: Why can't you use neostigmine for reversal?

Me: Neostigmine is renally cleared. In an ESRD patient, the drug will accumulate and the anti-cholinesterase effect will outlast the atropine or glycopyrrolate. There's a risk of re-curarization post-op when the glycopyrrolate wears off. Sugammadex is the clean answer here — it chelates the rocuronium directly, complete reversal, and its metabolites are inactive.

Examiner: Intraoperatively, the EKG develops peaked T-waves and a wide QRS. What do you do?

Me: I would treat this as hyperkalemia until proven otherwise. I'd push calcium chloride 1 gram IV immediately to stabilize the cardiac membrane. Then I'd hyperventilate to create a respiratory alkalosis, shifting K+ intracellularly. I'd give 50 mL of 50% dextrose and 10 units of insulin. I'd check an ABG with potassium level. If the QRS doesn't narrow within a few minutes despite treatment, I'm thinking about stopping the procedure and getting the patient back to dialysis.

Examiner: Post-op pain management — what's your plan?

Me: I'd avoid morphine and codeine — both have active renally-cleared metabolites that accumulate in ESRD and can cause respiratory depression and seizures. Hydromorphone is safer in small doses. Fentanyl is reasonable — it's primarily hepatically cleared. I'd lean on multimodal analgesia: acetaminophen, ketorolac (short course), and local infiltration if the surgeon can do it. I'd coordinate with nephrology for same-day or next-morning dialysis.

Key Phrases That Score Points

  • "Succinylcholine is contraindicated — his potassium is 5.3 and succinylcholine will push it to 6.3."
  • "Rocuronium with sugammadex reversal — neostigmine accumulates in ESRD and can cause re-curarization."
  • "Calcium chloride first for peaked T-waves — I'm stabilizing the cardiac membrane before anything else."
  • "Morphine is contraindicated in ESRD — active metabolites accumulate and cause respiratory depression."
  • "Same-day or next-morning dialysis — I'm coordinating this with nephrology before I leave PACU."

Why This Case Appears on the Boards

ESRD scenarios are a staple because they force you to modify every standard drug choice — induction agents, neuromuscular blockers, reversal agents, and opioids. The examiner is testing whether you can manage a "simple" laparoscopic case that becomes complex through systemic disease.